PharmAct ^Company

The Berlin-based company uses markers in the blood to detect everything from heart attacks to early signs of diabetes, offering results in less than 20 minutes. Harnessing that experience to find Covid-19 antibodies seemed within reach, says Burgard, PharmAct’s medical director. PharmAct’s $40 test kit are one tool that could allow governments and scientists to grasp the pandemic’s true scope. These antibody tests are at the forefront of a push to assess who has potentially built up some immunity to the new virus, even unknowingly, pinpointing who can probably leave confinement and start rebuilding shattered economies.